(Q32039075)

5 July 2017

title

Sevelamer hydrochloride (Renagel), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics (English)

1 reference

5 July 2017

0 references

1 reference

1 reference

Burke S

1

1 reference

5 July 2017

Amin N

2

1 reference

5 July 2017

Incerti C

3

1 reference

5 July 2017

Plone M

4

1 reference

5 July 2017

Watson N

5

1 reference

5 July 2017

publication date

1 February 2001

1 reference

The Journal of Clinical Pharmacology

5 July 2017

published in

1 reference

5 July 2017

volume

41

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

193-198

1 reference

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Decreased bioavailability of digoxin due to hypocholesterolemic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Effects of cholestyramine and colestipol on the plasma concentrations of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Enhanced elimination of warfarin during treatment with cholestyramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Interaction of warfarin and nonsystemic gastrointestinal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Apparent reduced absorption of gemfibrozil when given with colestipol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009872

10.1177/00912700122009872

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference